Clinicopathologic characteristics and prognostic of gastric cancer in young patients

医学 胃肠病学 内科学 癌症 胃切除术 阶段(地层学) 存活率 印戒细胞 腺癌 古生物学 生物
作者
Zhongjun Wang,Jun Xu,Zheng Shi,Xiaojun Shen,Tianghang Luo,Jianwei Bi,Mingming Nie
出处
期刊:Scandinavian Journal of Gastroenterology [Taylor & Francis]
卷期号:51 (9): 1043-1049 被引量:45
标识
DOI:10.1080/00365521.2016.1180707
摘要

Gastric cancer (GC) in young patients is thought to exhibit a worse prognosis due to specific clinicopathologic characteristics and delayed diagnosis; however, the data are controversial. This study aimed to analyse the clinicopathologic characteristics and prognostic factors of GC in young patients and to determine whether GC is a different clinical entity in younger vs. older patients.Clinical data of 3930 gastric cancer patients who underwent radical gastrectomy were retrospectively analysed and divided into two age groups. The younger group consisted of 342 cases of patients aged 40 years or younger at the time of surgery, and the older group included 3588 cases of patients older than 40 years. Clinicopathologic characteristics were compared using Pearson's χ(2) or Fisher's exact tests, and survival curves were constructed using the Kaplan-Meier method.Clinicopathologic characteristics of the younger group exhibited a predominance of females (p < 0.001), diffuse stomach lesions (p = 0.014), signet-ring cell type (p < 0.001), poorly differentiated histological tumours (p < 0.001), Borrmann type IV (p < 0.001), mixed Lauren's classification types (p = 0.004), and recurrence rate in the gastric remnant (p < 0.001). The overall 5-year survival rates in the younger group and older group were 60.8% and 53.7%, respectively (p = 0.017). When stratified by TNM stage, the younger group exhibited enhanced 5-year survival at stage IV compared with the older group (26.9% VS. 10.3%, p = 0.003).Although younger patients with GC exhibit more aggressive cancer patterns and higher recurrence rate in the gastric remnant, the overall 5-year survival rate may be better than older patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
夏尔酱发布了新的文献求助10
刚刚
1秒前
Yanny8完成签到,获得积分10
4秒前
上官若男应助畅chang采纳,获得10
4秒前
6秒前
6秒前
张家港最猛的1完成签到,获得积分20
7秒前
赘婿应助tao采纳,获得10
7秒前
Jeffery完成签到,获得积分10
8秒前
Jasper应助zhang采纳,获得10
8秒前
8秒前
stars完成签到,获得积分10
8秒前
烟花应助yang采纳,获得10
8秒前
8秒前
9秒前
zyx发布了新的文献求助10
11秒前
yhw发布了新的文献求助10
11秒前
13秒前
wjj119完成签到,获得积分10
13秒前
曾无忧发布了新的文献求助10
13秒前
orixero应助研友_Zza3qn采纳,获得10
14秒前
KYG发布了新的文献求助10
14秒前
15秒前
15秒前
Jeffery发布了新的文献求助30
16秒前
迷龙发布了新的文献求助10
17秒前
17秒前
睡不醒关注了科研通微信公众号
18秒前
18秒前
20秒前
Yoeyvol发布了新的文献求助10
21秒前
21秒前
畅chang发布了新的文献求助10
21秒前
一天一天发布了新的文献求助10
22秒前
星辰大海应助yy采纳,获得10
23秒前
Yatagarasu发布了新的文献求助10
23秒前
跳跃涵柳发布了新的文献求助10
23秒前
zhang发布了新的文献求助10
24秒前
科研通AI6.1应助单薄寻雪采纳,获得10
24秒前
KYG完成签到,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
Electrode Potentials 550
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6961323
求助须知:如何正确求助?哪些是违规求助? 8643875
关于积分的说明 18331039
捐赠科研通 6410623
什么是DOI,文献DOI怎么找? 3085970
关于科研通互助平台的介绍 2134558
邀请新用户注册赠送积分活动 2062421